DF
BIIB icon

Donoghue Forlines’s Biogen BIIB Stock Holding History

Donoghue Forlines’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,338
Closed -$801K – 265
2021
Q4 		$801K Buy
3,338
+1,078
+48% +$277K 0.14% 163
2021
Q3 		$640K Buy
+2,260
New +$741K 0.12% 170
2021
Q1 		– Sell
-3,973
Closed -$973K – 220
2020
Q4 		$973K Buy
+3,973
New +$1.02M 0.19% 154
2017
Q4 		– Sell
-6,984
Closed -$2.19M – 119
2017
Q3 		$2.19M Buy
+6,984
New +$2.07M 0.23% 80

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Donoghue Forlines's BIIB Position: Q1 2022 in Review

Donoghue Forlines sold out of Biogen (BIIB) in Q1 2022, closing a stake of 3,338 shares — an estimated $801K sold.

Donoghue Forlines first reported a position in BIIB in Q3 2017 and held it in 4 quarters. The position peaked at $2.19M in Q3 2017. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Donoghue Forlines reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Donoghue Forlines sold 3,338 Biogen shares in Q1 2022, an estimated $801K.
  • Donoghue Forlines first reported a position in Biogen in Q3 2017 and held it in 4 quarters.
  • Donoghue Forlines's Biogen position peaked at $2.19M in Q3 2017.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Donoghue Forlines's 13F filing for Q1 2022, filed 16 May 2022.